Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Takeda clinical trials
The registry lists 1,753 studies whose lead sponsor is Takeda or one of 10 companies grouped under it. 94 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Takeda studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Takeda.
- Takeda1,025 studiesSame company
Something wrong?
- 351 studies →
- Millennium Pharmaceuticals, Inc.178 studies →Acquired — became part of Takeda, May 9, 2008 · source ↗
Something wrong?
- 111 studies →
- 31 studies →
- 24 studies →
- 13 studies →
- 11 studies →
- 6 studies →
- 2 studies →
- 1 study →
Focus areas
Conditions Takeda leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Diabetes Mellitus109Crohn Disease85Diabetes Mellitus, Type 282Colitis, Ulcerative66Angioedemas, Hereditary60Hemophilia A60Ulcer56Lymphoma54Multiple Myeloma54Attention Deficit Disorder with Hyperactivity49Hypertension46Gastroesophageal Reflux44Neoplasms37Esophagitis, Peptic32Carcinoma, Non-Small-Cell Lung29Constipation29Depression26Depressive Disorder, Major26Short Bowel Syndrome25Esophagitis24Inflammatory Bowel Diseases24Primary Immunodeficiency Diseases24Essential Hypertension23Renal Insufficiency23
Show all 56 areas
Sleep Initiation and Maintenance Disorders22Dengue21Gaucher Disease20Prostatic Neoplasms20Mucopolysaccharidosis II19Duodenal Ulcer17Kidney Diseases17Hemophilia B16Hodgkin Disease16Lung Neoplasms16Fabry Disease15Colorectal Neoplasms14Kidney Failure, Chronic14Myelodysplastic Syndromes14Osteoporosis13Stomach Ulcer13Hypercholesterolemia12Hypoparathyroidism12Leukemia, Myeloid, Acute12Carcinoma11Fistula11Leukemia, Myelogenous, Chronic, BCR-ABL Positive11Mucopolysaccharidoses11Schizophrenia11Alpha 1-Antitrypsin Deficiency10Cytomegalovirus Infections10Gout10Liver Diseases10Lymphoma, Large-Cell, Anaplastic10Lymphoma, Non-Hodgkin10Narcolepsy10Purpura, Thrombotic Thrombocytopenic10
Studies
Recruiting first, then most recently updated. Showing 50 of 1,753. Browse all 1,753 →
- A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsRecruitingNCT06499285Phase 3
- A Study of Mezagitamab in Adults With Kidney Condition Called IgA NephropathyRecruitingNCT06963827Phase 3
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community SettingRecruitingNCT06581328Phase 4
- A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access ProgramRecruitingNCT07429942
- A Study of Zasocitinib in Adults With Non-pustular Palmoplantar PsoriasisNot yet recruitingNCT07752108Phase 3
- A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)RecruitingNCT04419649Phase 2
- A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood TransfusionsRecruitingNCT07422480Phase 3
- A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South KoreaRecruitingNCT07445087
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesRecruitingNCT06671483Phase 3
- A Study of TAK-188 in Adults With Advanced or Spreading Solid TumorsRecruitingNCT07205718Phase 1/2
- A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple MyelomaRecruitingNCT06980480Phase 3
- A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic PurpuraRecruitingNCT06441578
- A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic SyndromesRecruitingNCT07319845Phase 2
- A Study of Zasocitinib in Adults With Psoriatic Arthritis (LATITUDE PsA NeXt)Not yet recruitingNCT07871721Phase 3
- A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)RecruitingNCT06405087Phase 3
- A Study of Secondary Immunodeficiencies in Adults With Blood Cancers in Kazakhstan Who Have a Weakened Immune System (K-SIDE Study)Not yet recruitingNCT07868107
- A Study to Better Understand the Diagnosis and Treatment of Polycythaemia VeraNot yet recruitingNCT07868081
- A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)RecruitingNCT06952699Phase 2
- A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With AdzynmaRecruitingNCT07353099
- A Study of Rusfertide in Japanese Adults With Polycythemia VeraRecruitingNCT07648030Phase 2
- A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home InfusionNot yet recruitingNCT05669729
- A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney TransplantNot yet recruitingNCT07613359Phase 2
- A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking RuxolitinibRecruitingNCT07623161Phase 3
- A Study of Zasocitinib in Adults With Nonsegmental VitiligoRecruitingNCT07108283Phase 2
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT06233461Phase 2
- A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in PolandRecruitingNCT07623174
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)RecruitingNCT06095128Phase 4
- A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 3
- A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaRecruitingNCT07646678Phase 2/3
- Gaucher Disease Outcome Survey (GOS)RecruitingNCT03291223
Sponsor listed in the registry: Shire · First submitted before Shire became part of Takeda
- A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South KoreaRecruitingNCT06550882
- A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)RecruitingNCT05582993Phase 3
- A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06948318Phase 3
- A Study of TAK-505 in Adults With Solid TumorsRecruitingNCT07436728Phase 1/2
- A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruitingNCT07250802Phase 3
- Continuation Study of Zasocitinib in Adults With Psoriatic ArthritisRecruitingNCT07286058Phase 3
- A Study of TAK-664 in People With Primary Immunodeficiency Diseases Who Have Not Yet Been Treated With ImmunoglobulinsNot yet recruitingNCT07794735Phase 4
- A Study of Replagal in Children and Adults With Fabry Disease in IndiaRecruitingNCT05067868Phase 4
Sponsor listed in the registry: Shire · First submitted after Shire became part of Takeda
- A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive DisorderRecruitingNCT07204314Phase 3
- A Study of Rusfertide in Adults With Polycythemia Vera in ChinaNot yet recruitingNCT07765602Phase 2
- A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's DiseaseRecruitingNCT07403968Phase 2
- A Study of TAK-755 in Adults With Acute Ischemic StrokeRecruitingNCT07392450Phase 2
- A Survey of Maribavir Tablets in Participants With Cytomegalovirus InfectionRecruitingNCT06577363
- A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia ARecruitingNCT06461533
- A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary ImmunodeficiencyRecruitingNCT06565078
- A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung CancerRecruitingNCT07217301Phase 3
- A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's DiseaseRecruitingNCT06100289Phase 3
- A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic PouchitisRecruitingNCT06443502Phase 3
- A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C DeficiencyRecruitingNCT06590974
- A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver ProblemsRecruitingNCT06512454